| 摘要 |
Discloses the use of a derivative of aryl (or heteroaryl)azolylcarbinol of general formula (I) in which: Ar represents a phenyl radical or a thienyl radical, with no substitutions or optionally with 1, 2 or 3 equal or different substituents selected from the group comprised of fluorine, chlorine, bromine, methyl, trifluoromethyl and methoxy; R1 represents a hydrogen atom or a lower alkyl group from C1 to C4; R2 represents a dialkyl(C1-C4)aminoalkyl (C2-C3) or azaheterocyclylalkyl (C2-C3)radical; and Het represents a five-membered nitrogenated aromatic heterocycle that contains one to three nitrogen atoms, without substitutions or optionally substituted by 1 or 2 equal or different substituents selected from a group comprised by fluorine, chlorine, bromine and methyl; or one of its physiologically acceptable salts, in the production of a drug to treat urinary incontinence in mammals, including man.
|
